NCT07204392View on ClinicalTrials.gov

Unveiling the Germline Predisposition to Myeloproliferative Neoplasms

RecruitingOBSERVATIONAL

Enrollment

313

Participants

Timeline

Start Date

June 27, 2022

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions

Myeloproliferative DiseaseGermline Mutation

Trial Locations (1)

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors

lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER